
Validea's guru fundamental report assigns MCKESSON CORP (MCK), a large-cap growth stock in the Major Drugs industry, a 100% rating using Pim van Vliet's Multi-Factor Investor model. This top score, indicating strong interest, is based on the model's preference for low volatility stocks with strong momentum and high net payout yields. While MCK passed criteria for market cap and standard deviation, its momentum and net payout yield were neutral, positioning it as a compelling option for conservative, factor-based investment strategies.
McKesson Corp (MCK) has received a maximum 100% rating from Validea's Multi-Factor Investor model, based on the conservative, low-risk strategy of Pim van Vliet. This top-tier score signifies strong interest from the quantitative model, which prioritizes low-volatility stocks combined with momentum and high net payout yields. As a large-cap stock in the Major Drugs industry, MCK's profile aligns well with the model's core tenets, passing key tests for market capitalization and standard deviation, underscoring its stability. However, it is critical to note that the stock received only a 'Neutral' rating for its 'Twelve Minus One Momentum' and 'Net Payout Yield'. This suggests that while MCK excels on low-volatility metrics, its recent price performance and shareholder return profile are not primary drivers of this specific positive rating, indicating the model's heavy weighting towards stability over other factors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment